Biggest News Aggregation in the World
📰 Development Command News

Page 8 - Development Command News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Development Command. Real-time updates on events, politics, business and more.

Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury

CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translati...
David Dewahl Davida Dewahl Jr Ischemix Inc Altasciences Company Inc Health Affairs Us Army Medical Research

PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome

Planning underway for Phase 2 trial of LYT-300 in Fragile X-associated Tremor/Ataxia Syndrome LYT-300 is also being evaluated in a Phase 2a trial for anxiety disorders, and a Phase 2a in patients...
United States Christopher Porter Eric Elenko Randi Hagerman Angewandte Chemie Us Army Medical Research Acquisition Activity

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

U.S. Depleted Uranium to Make Ukraine War Dirtier

CounterPunch, BY JOHN LAFORGE, 30 June 23 The Biden administration is expected to supply Ukraine with highly controversial depleted-uranium munitions which are to be fired from the Abrams battle tanks the U.S. is sending to Kyiv, the Wall St. Journal reported June 13. Any delivery of U.S. depleted uranium (DU) weapons to Ukraine would be in addition…
City Of United Kingdom New York United States John Pilger Phil Miller Sergei Lavrov

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science